4549.T
EIKEN CHEMICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 2,324.00
−0.21%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 41.9B | 41.9B | 40.5B | 40.1B | 43.3B |
| Cost of Revenue | 6.1B | 25.7B | 24.0B | 23.3B | 22.8B |
| Gross Profit | 4.1B | 16.2B | 16.5B | 16.7B | 20.5B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 3.3B | 13.3B | 13.5B | 13.3B | 13.0B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.3B | 13.3B | 13.5B | 13.3B | 13.0B |
| Cost and Expenses | 39.0B | 39.0B | 37.5B | 36.7B | 35.8B |
| Operating Income (EBIT) | 2.9B | 2.9B | 3.0B | 3.4B | 7.5B |
| Non-Operating | |||||
| Interest Income | 4.0M | 17.0M | 14.0M | 8.0M | 15.0M |
| Interest Expense | 4.0M | 29.0M | 17.0M | 17.0M | 16.0M |
| Net Interest Income | — | (12.0M) | (3.0M) | (9.0M) | (1.0M) |
| Other Non-Op Income/Expense | 13.0M | (75.0M) | 199.0M | 191.0M | 112.0M |
| Non-Operating Income (excl Interest) | 41.0M | 147.0M | 221.0M | 276.0M | 139.0M |
| EBT (Pre-Tax Income) | 814.0M | 4.8B | 3.0B | 3.5B | 7.6B |
| Income Tax Expense | 214.0M | 1.1B | 763.0M | 869.0M | 1.9B |
| Bottom Line | |||||
| Net Income | 3.7B | 3.7B | 2.2B | 2.6B | 5.7B |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 3.7B | 3.7B | 2.2B | 2.6B | 5.7B |
| Per Share | |||||
| Basic EPS | ¥113 | ¥112 | ¥65 | ¥72 | ¥155 |
| Diluted EPS | ¥113 | ¥112 | ¥64 | ¥71 | ¥154 |
| Revenue Per Share | ¥1,271 | ¥1,271 | ¥1,179 | ¥1,090 | ¥1,171 |
| Shares | |||||
| Basic Shares Outstanding | 33.0M | 33.0M | 34.4M | 36.7M | 37.0M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 5.5B | 5.6B | 5.7B | 9.6B |
| D&A | — | 2.5B | 2.6B | 2.3B | 2.1B |
| EBIT | 2.9B | 2.9B | 3.0B | 3.4B | 7.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026